Microarray Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments) and Services, By Type, By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

Report Overview

The global microarray market size was valued at USD 5.58 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2030. Microarrays have received attention for their use in high-throughput genetic analysis and molecular profiling for cancer research, genetic disorders, and infectious disease diagnosis. Due to increased technological advancements, the rise in demand for genetic analysis, and enhanced investment in research and development, the global infrastructure for microarrays is poised to grow significantly in the future.

Personalized medicine is also a contributing factor as researchers can use these tools to identify specific markers of diseases enabling targeted therapies. Microarrays in diagnostics, forensic science, and agricultural biotechnology have further strengthened the market’s expansion.

The increasing emphasis on early disease detection and preventative healthcare will drive market growth. Microarrays help researchers and clinicians pinpoint early signs of bio-markers related to various conditions, allowing them to make timely interventions to improve patient outcomes. Early detection is crucial in oncology, where microarrays can identify the genes responsible for tumor growth, facilitating preventive and individualized treatments.

Expanding research in environmental monitoring and agricultural biotechnology will drive market growth. Microarrays serve as essential tools for the farm study of plant genomes and enhance productivity by recognizing genetic characteristics that protect against pathogens and climatic changes. Additionally, worldwide, food security has emerged as a major problem, microarrays provide vital information on transgenic modifications and improvements in agriculture. In environmental science, they are used to assess pollutant effects on gene expression patterns among living organisms, hence supporting sustainability initiatives and eco-conservation programs. Therefore, the diverse applicability of microarray technology within different disciplines is another factor driving product demand.

Product and Services Insights

Consumables dominated the market and accounted for 59.8% in 2023 attributed to the consistency in buying and substitution of microscopic array agents, signs, and additional disposable items necessary for genetic examination and molecular profiling. Additionally, gene transcription profiling and single-nucleotide polymorphism (SNP) genotyping are among the many microchip applications used in diagnostics and research, creating higher demand for consumables. The need for precise and trustworthy high-end consumables drives market growth.

Software and services are expected to register a CAGR of 5.7% during the forecast period. The growth is due to the rising demand for tools to analyze and interpret data to handle the great volume of data created from microarray experiments. Additionally, the growing use of microarrays in research and diagnostic applications has resulted in high demand for customized software and services to assist researchers in analyzing and interpreting complex data sets. Services such as data analysis, reporting, and outsourcing to third-party providers boost the segment’s growth.

Type Insights

The DNA microarray segment dominated the market in 2023driven by its widespread adoption in genetic research, disease diagnosis, and drug discovery applications. The DNA microarray technology has allowed for the simultaneous analysis of thousands of genes and genetic variations, thus acting as an essential tool for understanding complex biological systems and identifying potential biomarkers for diseases. The improvements in the sensitivity and specificity of DNA microarray systems have driven its growth and turned it into the largest segment in the global market.

The protein microarray segment is projected to grow at a CAGR of 6.2% over the forecast period, driven by the increasing demand for high-throughput protein analysis in research and diagnostic applications. The growing interest in protein-protein interactions and protein function, and the discovery of protein disease biomarkers, have led to greater uptake of these devices that allow the simultaneous analysis of thousands of proteins.  Advancements in sensitivity and multiplexing capabilities contribute to the growth of this segment, enabling researchers to understand and interpret complex biological systems and develop diagnosis strategies.

Application Insights

The research application segment dominated the market in 2023 due to their application in areas of research such as transcriptomics, proteomics, and genomics. In addition, the increasing necessity of comprehending intricate biological systems, recognizing disease biomarkers, and advancing personalized medicine strategies in research applications is anticipated to drive market growth. The funding from governments and grants issued for research projects is expected to increase the number of research institutions and universities that have contributed to its growth.

The disease diagnostics segment is projected to grow at a CAGR of 6.3% over the forecast period. This is attributed to using microarrays in clinical diagnostics for early disease detection, diagnosis, and monitoring. In addition, the growing need for personalized medicine and targeted therapies, which help healthcare professionals identify specific genetic biomarkers and formulate appropriate treatment strategies is anticipated to drive market growth. The advancements in microarray technology such as improved sensitivity and specificity have propelled growth in this sector allowing accurate diagnoses of complicated diseases such as cancer, genetic disorders, and infectious illnesses.

End Use Insights

The research and academic institutes segment dominated with a share of 37.7% in 2023. This is driven by the high demand for microarrays in various research applications, including genomics, proteomics, and transcriptomics. The availability of government funding and grants for research projects has enabled research and academic institutes to invest in microarray technology, further fueling the segment growth. Additionally, the need for advanced research tools and technologies to stay competitive in the scientific community has also driven the adoption of microarrays in research and academic institutes, making it the largest contributor to the global microarray market.

The pharmaceutical and biotechnology companies segment is projected to grow at a CAGR of 6.4% over the forecast period. This is due to factors such as the increasing adoption of microarrays in drug discovery and development and biomarker identification and validation. Additionally, the growth of targeted therapies and personalized medicine has increased the demand for microarrays among pharmaceutical and biotechnology companies, enabling them to identify specific genetic biomarkers and develop suitable treatment strategies. Furthermore, investment in R&D activities is anticipated to drive the segment growth since they help understand complex biological systems and identify new drug targets.

Regional Insights

North America microarray dominated the market with a share of 45.5% in 2023 driven by the presence of research institutions, and pharmaceutical, and biotechnology companies, which has fueled the demand for microarrays in the region. The high adoption rate of advanced technologies, such as next-generation sequencing, and the growing investment in research and development activities, particularly in the U.S., has further driven the growth of the microarray market in North America. Additionally, the region's well-established healthcare infrastructure and favorable government policies supporting research and innovation have created a conducive environment for the growth of microarray market, making North America the largest contributor to the global market.

U.S. Microarray Market Trends

The U.S. microarray market dominated the North American region with a share of 88.3% in 2023. This is due to its strong investment in biotechnology research and development, alongside a robust infrastructure for advanced medical and genomic technologies. Additionally, the presence of leading microarray manufacturers and extensive funding for research initiatives and clinical studies are anticipated to drive market growth.

Europe Microarray Market Trends

Europe microarray market witnessed substantial growth in 2023 due to the region's strong research infrastructure, including numerous academic institutions and research centers, which has led to increased adoption of microarrays in various applications, including genomics, proteomics, and diagnostics. Additionally, government initiatives and funding programs, such as the European Union's Horizon, have supported research and innovation in the life sciences sector, further fueling the growth of the microarray market in Europe.

The UK microarray market is expected to grow substantially in the forthcoming years due to the country's strong research and development infrastructure, including world-class universities and research institutions, which continue to drive innovation and adoption of microarray technology. Additionally, the UK's National Health Service (NHS) and government initiatives, such as the UK's Precision Medicine Strategy, will further fuel the growth, as there is an increased focus on personalized medicine, genomics, and targeted therapies.

Asia Pacific Microarray Market Trends

Asia Pacific microarray market is anticipated to witness significant growth, driven by the increasing investment in research and development activities, particularly in countries such as China, Japan, and South Korea, which are rapidly emerging as hubs for biotechnology and pharmaceutical research. Additionally, the growing demand for personalized medicine, rising healthcare expenditure, and improving research infrastructure in the region will further fuel the growth of the microarray market in the Asia Pacific, making it an attractive destination for market players.

China microarray market held a substantial share in 2023 due to the country's significant investments in genomics and precision medicine initiatives, such as the China Precision Medicine Initiative, which has driven the adoption of microarray technology in research and diagnostic applications. Additionally, China's large patient population, growing biotechnology industry, and increasing government support for research and development activities have further fueled the industry expansion.  

Microarray Market Share Insights

Some key companies in the global microarray market include Thermo Fisher Scientific Inc, Agilent Technologies, Inc, Illumina, Inc, PerkinElmer, and others. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions and partnerships with other major companies. 

• Thermo Fisher Scientific Inc. is a provider in the global microarray market, offering a wide range of innovative products for genomic analysis and research. Their portfolio includes advanced microarray solutions that support various applications, such as gene expression profiling, genetic variation studies, and personalized medicine.

• Illumina, Inc. is a key player in the global microarray market, specializing in high-throughput sequencing and array-based technologies for genomic research. Their product offerings include advanced microarray platforms that enable comprehensive genetic analysis, facilitating insights into gene expression, genetic variation, and disease mechanisms.

Recent Developments

• In August 2024, Illumina, Inc. announced the launch of its NovaSeqX series, a new line of sequencing systems that promises to deliver faster, more cost-effective genomic sequencing. The NovaSeqX series features enhanced performance and scalability, aimed at accelerating research and improving data accessibility for a range of applications. This advancement supports comprehensive genetic studies and facilitates breakthroughs in personalized medicine and genomics.

• In January 2024, Thermo Fisher Scientific introduced the Pangenomix Array, a new genomic tool designed to enhance the study of genetic variations across diverse population. This advanced array provides comprehensive coverage of human genetic diversity, facilitating more accurate genetic research and personalized medicine.

Microarray Market Report Scope

Global Microarray Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global microarray market report based on product and services, type, application, end use, and region.

• Product and Services Outlook (Revenue, USD Million, 2018 - 2030)

  • Consumables

  • Instruments

  • Software and Services

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • DNA Microarray

  • Protein Microarray

  • Others

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Research Applications

  • Drug Discovery

  • Disease Diagnostics

  • Others Applications

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Research and Academic Institutes

  • Pharmaceutical and Biotechnology Companies

  • Diagnostic Laboratories

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait